US FDA may inspect Sun Pharma’s Halol site in February: Sources

MUMBAI: The US Food and Drug Administration is expected to begin inspection of Sun Pharma’s manufacturing facility at Halol in the second week of February, sources told ET. The much-awaited inspection is critical as the facility produces multiple medicines from tablets to ointments and injectables.

Read More

US FDA takes new steps to facilitate efficient generics review to enhance competition, promote access & lower drug prices

US FDA takes new steps to facilitate efficient generics review to enhance competition, promote access & lower drug prices

Read More